vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Smith Douglas Homes Corp. (SDHC). Click either name above to swap in a different company.
Smith Douglas Homes Corp. is the larger business by last-quarter revenue ($260.4M vs $205.4M, roughly 1.3× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 1.4%, a 6.9% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -9.4%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $8.7M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 17.3%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
COLL vs SDHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $260.4M |
| Net Profit | $17.0M | $3.5M |
| Gross Margin | 62.5% | 19.9% |
| Operating Margin | 29.6% | 6.5% |
| Net Margin | 8.3% | 1.4% |
| Revenue YoY | 12.9% | -9.4% |
| Net Profit YoY | 35.3% | -14.3% |
| EPS (diluted) | $0.48 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $260.4M | ||
| Q3 25 | $209.4M | $262.0M | ||
| Q2 25 | $188.0M | $223.9M | ||
| Q1 25 | $177.8M | $224.7M | ||
| Q4 24 | $181.9M | $287.5M | ||
| Q3 24 | $159.3M | $277.8M | ||
| Q2 24 | $145.3M | $220.9M | ||
| Q1 24 | $144.9M | $189.2M |
| Q4 25 | $17.0M | $3.5M | ||
| Q3 25 | $31.5M | $2.1M | ||
| Q2 25 | $12.0M | $2.4M | ||
| Q1 25 | $2.4M | $2.7M | ||
| Q4 24 | $12.5M | $4.1M | ||
| Q3 24 | $9.3M | $5.3M | ||
| Q2 24 | $19.6M | $3.6M | ||
| Q1 24 | $27.7M | $3.0M |
| Q4 25 | 62.5% | 19.9% | ||
| Q3 25 | 61.7% | 21.0% | ||
| Q2 25 | 57.7% | 23.2% | ||
| Q1 25 | 54.8% | 23.8% | ||
| Q4 24 | 54.0% | 25.5% | ||
| Q3 24 | 60.8% | 26.5% | ||
| Q2 24 | 62.5% | 26.7% | ||
| Q1 24 | 63.1% | 26.1% |
| Q4 25 | 29.6% | 6.5% | ||
| Q3 25 | 29.7% | 6.6% | ||
| Q2 25 | 18.7% | 7.7% | ||
| Q1 25 | 12.2% | 8.7% | ||
| Q4 24 | 20.9% | 10.4% | ||
| Q3 24 | 21.9% | 14.2% | ||
| Q2 24 | 32.7% | 11.7% | ||
| Q1 24 | 34.1% | 11.3% |
| Q4 25 | 8.3% | 1.4% | ||
| Q3 25 | 15.0% | 0.8% | ||
| Q2 25 | 6.4% | 1.1% | ||
| Q1 25 | 1.4% | 1.2% | ||
| Q4 24 | 6.9% | 1.4% | ||
| Q3 24 | 5.9% | 1.9% | ||
| Q2 24 | 13.5% | 1.7% | ||
| Q1 24 | 19.1% | 1.6% |
| Q4 25 | $0.48 | $0.39 | ||
| Q3 25 | $0.84 | $0.24 | ||
| Q2 25 | $0.34 | $0.26 | ||
| Q1 25 | $0.07 | $0.30 | ||
| Q4 24 | $0.36 | $0.50 | ||
| Q3 24 | $0.27 | $0.58 | ||
| Q2 24 | $0.52 | $0.40 | ||
| Q1 24 | $0.71 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $12.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $86.7M |
| Total Assets | $1.7B | $557.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $12.7M | ||
| Q3 25 | $285.9M | $14.8M | ||
| Q2 25 | $222.2M | $16.8M | ||
| Q1 25 | $197.8M | $12.7M | ||
| Q4 24 | $162.8M | $22.4M | ||
| Q3 24 | $120.0M | $23.7M | ||
| Q2 24 | $271.6M | $17.3M | ||
| Q1 24 | $318.0M | $32.8M |
| Q4 25 | $301.7M | $86.7M | ||
| Q3 25 | $274.8M | $82.2M | ||
| Q2 25 | $232.2M | $80.0M | ||
| Q1 25 | $234.4M | $76.9M | ||
| Q4 24 | $228.8M | $73.6M | ||
| Q3 24 | $234.3M | $68.4M | ||
| Q2 24 | $216.6M | $62.1M | ||
| Q1 24 | $222.2M | $59.7M |
| Q4 25 | $1.7B | $557.6M | ||
| Q3 25 | $1.6B | $571.6M | ||
| Q2 25 | $1.6B | $570.2M | ||
| Q1 25 | $1.6B | $513.9M | ||
| Q4 24 | $1.7B | $475.9M | ||
| Q3 24 | $1.6B | $460.1M | ||
| Q2 24 | $1.1B | $429.3M | ||
| Q1 24 | $1.1B | $401.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $9.8M |
| Free Cash FlowOCF − Capex | $122.4M | $8.7M |
| FCF MarginFCF / Revenue | 59.6% | 3.4% |
| Capex IntensityCapex / Revenue | 0.3% | 0.4% |
| Cash ConversionOCF / Net Profit | 7.25× | 2.77× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $-36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $9.8M | ||
| Q3 25 | $78.4M | $22.8M | ||
| Q2 25 | $72.4M | $-28.9M | ||
| Q1 25 | $55.4M | $-34.9M | ||
| Q4 24 | $84.6M | $5.5M | ||
| Q3 24 | $-9.0M | $22.9M | ||
| Q2 24 | $67.4M | $39.0K | ||
| Q1 24 | $61.9M | $-9.3M |
| Q4 25 | $122.4M | $8.7M | ||
| Q3 25 | $78.3M | $21.4M | ||
| Q2 25 | $72.4M | $-31.1M | ||
| Q1 25 | $54.6M | $-35.9M | ||
| Q4 24 | $84.1M | $4.8M | ||
| Q3 24 | $-9.2M | $22.3M | ||
| Q2 24 | $67.1M | $-2.1M | ||
| Q1 24 | $61.4M | $-9.7M |
| Q4 25 | 59.6% | 3.4% | ||
| Q3 25 | 37.4% | 8.2% | ||
| Q2 25 | 38.5% | -13.9% | ||
| Q1 25 | 30.7% | -16.0% | ||
| Q4 24 | 46.2% | 1.7% | ||
| Q3 24 | -5.8% | 8.0% | ||
| Q2 24 | 46.2% | -1.0% | ||
| Q1 24 | 42.3% | -5.1% |
| Q4 25 | 0.3% | 0.4% | ||
| Q3 25 | 0.1% | 0.5% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.4% | 0.5% | ||
| Q4 24 | 0.3% | 0.2% | ||
| Q3 24 | 0.2% | 0.2% | ||
| Q2 24 | 0.2% | 1.0% | ||
| Q1 24 | 0.4% | 0.2% |
| Q4 25 | 7.25× | 2.77× | ||
| Q3 25 | 2.49× | 10.70× | ||
| Q2 25 | 6.05× | -12.24× | ||
| Q1 25 | 22.92× | -13.01× | ||
| Q4 24 | 6.75× | 1.33× | ||
| Q3 24 | -0.96× | 4.28× | ||
| Q2 24 | 3.44× | 0.01× | ||
| Q1 24 | 2.23× | -3.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
SDHC
| Southeast | $164.7M | 63% |
| Central | $95.8M | 37% |
